Astrazeneca (AZN) Return on Equity [ROE] (2009 - 2026)
Astrazeneca's Return on Equity [ROE] came in at 21.60% for Q3 2026, up 0.88 percentage points from 20.72% a year earlier and up 0.21 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Astrazeneca's Return on Equity [ROE] was 22.84%, up 5.25 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +2.05 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 17.59% in FY2024 (+1.95 pp), 15.64% in FY2023 and 0.42% in FY2021 (-20.38 pp).
- The five-year range for quarterly Return on Equity [ROE] is -3.45% (Q2 2022) to 21.63% (Q1 2026).
- Year-over-year, Return on Equity [ROE] has increased for nine consecutive quarters, with an average year-over-year change of +2.65 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2023 (a gain of 20.30 percentage points), and the weakest in Q1 2022 (a drop of 38.19 percentage points).
- Business Quant data shows AZN's Return on Equity [ROE] at 21.39% (Q2 2026), 21.63% (Q1 2026) and 21.61% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 4.66% |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 19.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.60% |
| Jun 30, 2026 | 21.39% |
| Mar 31, 2026 | 21.63% |
| Dec 31, 2025 | 21.61% |
| Sep 30, 2025 | 20.72% |
| Jun 30, 2025 | 19.32% |
| Mar 31, 2025 | 18.98% |
| Dec 31, 2024 | 17.24% |
| Sep 30, 2024 | 16.17% |
| Jun 30, 2024 | 16.72% |
| Mar 31, 2024 | 16.53% |
| Dec 31, 2023 | 15.61% |
| Sep 30, 2023 | 15.82% |
| Jun 30, 2023 | 16.85% |
| Mar 31, 2023 | 12.92% |
| Dec 31, 2022 | 9.12% |
| Sep 30, 2022 | 5.75% |
| Jun 30, 2022 | -3.45% |
| Mar 31, 2022 | -2.80% |
| Dec 31, 2021 | 0.29% |
API Access
Astrazeneca Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();